VI
Vivimed Labs Ltd.
VIVIMEDLAB.NS · NSE
₹5.99 +4.90% (+₹0.28)
1M -11.47%
Market Cap ₹473.4M
P/E Ratio -
Div. Yield -
ROE -
Bulios Fair Price
₹4.74
20.9% downside
Current Price
₹5.99
Undervalued Fair Value Overvalued
According to Bulios Fair Price, VIVIMEDLAB.NS is currently overvalued relative to its market price. How does it work?
Bulios Fair Price is an estimate of a stock's fair value from the Bulios valuation model. It is an input for your own analysis, not investment advice. How does it work?
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
100 /100
Cheap P/FCF 7.01x
P/S 0.68x
EV/EBITDA N/A
Growth
0 /100
Declining FCF growth 39.40%
Rev. growth 27.95%
Book val. growth N/A
Profitability
19 /100
Weak Net margin 252.14%
Op. margin 255.03%
FCF margin 9.65%
Quality
2 /100
Poor ROA 23.42%
Asset turnover 0.09x
ROIC 28.30%
Debt
0 /100
High Int. coverage -41.17x
Current ratio 0.37x
Net debt/EBITDA N/A
Stability
52 /100
Moderate Rev. volatility 10.79%
EPS volatility 294.25%
Profitable years 0
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about VIVIMEDLAB.NS
Online
Sector
Healthcare
Industry
Drug Manufacturers - Specialty & Generic
CEO
Manohar Rao Varalwar
Employees
586
Headquarters
Hyderabad